Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187

被引:57
作者
Gedulin, Bronislava R. [1 ]
Jodka, Carolyn M. [1 ]
Herrmann, Kathrin [1 ]
Young, Andrew A. [1 ]
机构
[1] Amylin Pharmaceut Inc, San Diego, CA 92121 USA
关键词
AC187; glucagon; gastric emptying;
D O I
10.1016/j.regpep.2006.06.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Amylin is a 37-amino acid polypeptide co-secreted with insulin from the pancreatic beta-cells. It complements insulin's stimulation of the rate of glucose disappearance (R-d) by slowing the rate of glucose appearance (R-a) through several mechanisms, including an inhibition of mealtime glucagon secretion and a slowing of gastric emptying. To determine if endogenous amylin tonically inhibits these processes, we studied the effects of the amylin receptor blocker AC187 upon glucagon secretion during euglycemic, hyperinsulinemic clamps in Sprague-Dawleyl (R) (HSD) rats, upon gastric emptying in HSD rats, and upon gastric emptying and plasma glucose profile in hyperamylinemic, and genetically obese, Lister Albany/NIH rats during a glucose challenge. Amylin blockade increased glucagon concentration, accelerated gastric emptying of liquids, and resulted in an exaggerated post-challenge glycemia. These data collectively indicate a physiologic role for amylin in glucose homeostasis via mechanisms that include regulation of glucagon secretion and gastric emptying. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 52 条
[1]  
ARNELO U, 1997, P NEUR ABSTR, V23
[2]   DIFFERENTIAL ANTAGONISM OF AMYLINS METABOLIC AND VASCULAR ACTIONS WITH AMYLIN RECEPTOR ANTAGONISTS [J].
BEAUMONT, K ;
MOORE, CX ;
PITTNER, RA ;
PRICKETT, KS ;
GAETA, LSL ;
RINK, TJ ;
YOUNG, AA .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (07) :1025-1029
[3]  
BEAUMONT K, 1993, MOL PHARMACOL, V44, P493
[4]  
BENNET WM, 1994, DIABETOLOGIA, V37, P436
[5]   COMPARATIVE DISTRIBUTION OF RECEPTORS FOR AMYLIN AND THE RELATED PEPTIDES CALCITONIN-GENE-RELATED PEPTIDE AND CALCITONIN IN RAT AND MONKEY BRAIN [J].
CHRISTOPOULOS, G ;
PAXINOS, G ;
HUANG, XF ;
BEAUMONT, K ;
TOGA, AW ;
SEXTON, PM .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (07) :1037-1041
[6]   Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product [J].
Christopoulos, G ;
Perry, KJ ;
Morfis, M ;
Tilakaratne, N ;
Gao, YY ;
Fraser, NJ ;
Main, MJ ;
Foord, SM ;
Sexton, PM .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :235-242
[7]   PURIFICATION AND CHARACTERIZATION OF A PEPTIDE FROM AMYLOID-RICH PANCREASES OF TYPE-2 DIABETIC-PATIENTS [J].
COOPER, GJS ;
WILLIS, AC ;
CLARK, A ;
TURNER, RC ;
SIM, RB ;
REID, KBM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8628-8632
[8]  
Edwards G., 1998, NEUROGASTROENT MOTIL, V10, P26
[9]   The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus [J].
Fineman, M ;
Weyer, C ;
Maggs, DG ;
Strobel, S ;
Kolterman, OG .
HORMONE AND METABOLIC RESEARCH, 2002, 34 (09) :504-508
[10]   The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type I diabetes [J].
Fineman, MS ;
Koda, JE ;
Shen, LZ ;
Strobel, SA ;
Maggs, DG ;
Weyer, C ;
Kolterman, OG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (05) :636-641